Author

David G. Parkes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Anastasia TsakmakiiD· 1 shared DAVID G. MAGGS· 1 shared Gavin A. BewickiD· 1 shared Harith RajagopalaniD· 1 shared Jason A. WestiD· 1 shared Philip J. Pedersen· 1 shared Rikke Veggerby Grønlund· 1 shared Soumitra S. GhoshiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Anastasia TsakmakiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Peptide-based GIP receptor inhibition produces limited metabolic improvements in mice whether alone or combined with GLP-1 agonism.

Jason A. West, Soumitra S. Ghosh, David G. Parkes, Anastasia Tsakmaki, Rikke Veggerby Grønlund, Philip J. Pedersen, DAVID G. MAGGS, Harith Rajagopalan, Gavin A. Bewick

This study evaluates the metabolic effects of peptide-based GIP receptor antagonists alone or combined with GLP-1 agonism in mice, finding limited benefits from antagonists alone but some synergistic effects when combined with GLP-1.

bioRxiv · Oct 29, 2019 · PreprintPhysiology